tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RHHVF Stock Latest News

Oppenheimer says Roche’s commitment to Veeva Vault CRM carries greater weight
The FlyOppenheimer says Roche’s commitment to Veeva Vault CRM carries greater weight
5d ago
CHRO
VEEV
Lineage Cell says first OpRegen development milestone under Roche pact achieved
PremiumThe Fly
Lineage Cell says first OpRegen development milestone under Roche pact achieved
6d ago
CHRO
LCTX
Lineage Cell’s OpRegen shows evidence of progress, says H.C. Wainwright
PremiumThe Fly
Lineage Cell’s OpRegen shows evidence of progress, says H.C. Wainwright
6d ago
CHRO
LCTX
Prothena price target raised to $8 from $4 at BofA
PremiumThe Fly
Prothena price target raised to $8 from $4 at BofA
6d ago
NVO
CHRO
Veeva announces expanded partnership with Roche Pharmaceuticals
PremiumThe Fly
Veeva announces expanded partnership with Roche Pharmaceuticals
6d ago
CHRO
VEEV
Olema Oncology price target raised to $40 from $20 at Guggenheim
PremiumThe FlyOlema Oncology price target raised to $40 from $20 at Guggenheim
10d ago
CHRO
OLMA
Roche announces EC granted conditional marketing approval of Lunsumio SC
Premium
The Fly
Roche announces EC granted conditional marketing approval of Lunsumio SC
11d ago
CHRO
Olema Oncology price target raised to $45 from $22 at Oppenheimer
Premium
The Fly
Olema Oncology price target raised to $45 from $22 at Oppenheimer
12d ago
CHRO
OLMA
Roche Stock (ROG) Soars on Positive Phase III Breast Cancer Trial Data
PremiumMarket News
Roche Stock (ROG) Soars on Positive Phase III Breast Cancer Trial Data
12d ago
OLMA
Genentech announces lidERA Breast Cancer study meets primary endpoint
PremiumThe Fly
Genentech announces lidERA Breast Cancer study meets primary endpoint
12d ago
CHRO
Midday Fly By: AMD sees acceleration, IBM unveils quantum processor
PremiumThe Fly
Midday Fly By: AMD sees acceleration, IBM unveils quantum processor
18d ago
C
T
Pharma firms spending billions on treatments based off old drugs, Bloomberg says
PremiumThe Fly
Pharma firms spending billions on treatments based off old drugs, Bloomberg says
18d ago
BMY
MRK
FDA appoints Richard Pazdur as Director of CDER
PremiumThe FlyFDA appoints Richard Pazdur as Director of CDER
18d ago
AZN
BMY
Roche upgraded to Hold from Sell at Deutsche Bank
Premium
The Fly
Roche upgraded to Hold from Sell at Deutsche Bank
19d ago
CHRO
Genentech reports first relapsing multiple sclerosis trial met primary endpoint
Premium
The Fly
Genentech reports first relapsing multiple sclerosis trial met primary endpoint
20d ago
CHRO
Nokia Roche
PremiumThe Fly
Nokia Roche
20d ago
NOK
CHRO
Nokia appoints Kristen Pressner as chief people officer
PremiumThe Fly
Nokia appoints Kristen Pressner as chief people officer
20d ago
NOK
CHRO
Genentech reports ALLEGORY study meets primary endpoint, secondary endpoints
PremiumThe Fly
Genentech reports ALLEGORY study meets primary endpoint, secondary endpoints
27d ago
CHRO
FDA moves to accelerate biosimilar development, lower drug costs
PremiumThe Fly
FDA moves to accelerate biosimilar development, lower drug costs
1M ago
AZN
BMY
Roche price target raised to CHF 255 from CHF 245 at Morgan Stanley
PremiumThe FlyRoche price target raised to CHF 255 from CHF 245 at Morgan Stanley
1M ago
CHRO
Roche receives CE mark for Elecsys Dengue Ag test
Premium
The Fly
Roche receives CE mark for Elecsys Dengue Ag test
1M ago
CHRO
Genentech announces INShore study of Gazyva meets primary endpoint
Premium
The Fly
Genentech announces INShore study of Gazyva meets primary endpoint
1M ago
CHRO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >